FLT3 Y842C
|
AML
|
FLT3 Y842C
|
AML
|
quizartinib Resistant: C3 – Early Trials
|
quizartinib Resistant: C3 – Early Trials
|
FLT3 Y842C
|
AML
|
FLT3 Y842C
|
AML
|
ponatinib Resistant: D – Preclinical
|
ponatinib Resistant: D – Preclinical
|
FLT3 Y842C
|
AML
|
FLT3 Y842C
|
AML
|
sorafenib Resistant: D – Preclinical
|
sorafenib Resistant: D – Preclinical
|
FLT3 Y842C
|
AML
|
FLT3 Y842C
|
AML
|
sorafenib + ARO-002 Sensitive: D – Preclinical
|
sorafenib + ARO-002 Sensitive: D – Preclinical
|